𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Phase II, Randomized, Double-Blind, Parallel-group, Placebo-Controlled, Oral Food Challenge Trial of XOLAIR® (omalizumab) in Peanut Allergy (TOPS)

✍ Scribed by Sampson, H.A.


Book ID
119278410
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
43 KB
Volume
119
Category
Article
ISSN
1097-6825

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES